Tieton Capital Management Llc decreased its stake in Myriad Genetics (MYGN) by 24.88% based on its latest 2018Q3 regulatory filing with the SEC. Tieton Capital Management Llc sold 30,450 shares as the company’s stock declined 33.25% with the market. The institutional investor held 91,948 shares of the health care company at the end of 2018Q3, valued at $4.23 million, down from 122,398 at the end of the previous reported quarter. Tieton Capital Management Llc who had been investing in Myriad Genetics for a number of months, seems to be less bullish one the $2.31 billion market cap company. The stock increased 1.78% or $0.55 during the last trading session, reaching $31.46. About 1.24 million shares traded or 31.04% up from the average. Myriad Genetics, Inc. (NASDAQ:MYGN) has declined 5.65% since February 17, 2018 and is downtrending. It has underperformed by 5.65% the S&P500. Some Historical MYGN News: 12/03/2018 – MYRIAD GENETICS INC – TIME PERIOD COVERED BY SUBPOENA IS JANUARY 1, 2014 THROUGH DATE OF ISSUANCE OF SUBPOENA; 03/05/2018 – Myriad Lawsuit: Bernstein Liebhard LLP Reminds Investors of Important Deadline in Class Action Against Myriad Genetics, Inc. – MYGN; 08/05/2018 – The Klein Law Firm Announces a Class Action Commenced on Behalf of Myriad Genetics, Inc. Shareholders and a Lead Plaintiff; 31/05/2018 – GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Set; 26/04/2018 – The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Myriad; 23/05/2018 – Myriad Announces Seven New Payer Coverage Decisions for Prolaris®; 08/05/2018 – Myriad Genetics Sees FY18 Adj EPS $1.19-Adj EPS $1.21; 31/05/2018 – GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting; 27/04/2018 – Myriad Genetics Presenting at Bank of America Conference May 16; 06/03/2018 Myriad Applauds AACU Position Statement on Molecular Testing for Risk Stratification in Prostate Cancer

Parkside Financial Bank & Trust decreased its stake in Phillips 66 Partners Lp (PSXP) by 41.44% based on its latest 2018Q3 regulatory filing with the SEC. Parkside Financial Bank & Trust sold 10,825 shares as the company’s stock declined 13.12% with the market. The institutional investor held 15,300 shares of the natural gas distribution company at the end of 2018Q3, valued at $782,000, down from 26,125 at the end of the previous reported quarter. Parkside Financial Bank & Trust who had been investing in Phillips 66 Partners Lp for a number of months, seems to be less bullish one the $6.21 billion market cap company. The stock decreased 2.60% or $1.34 during the last trading session, reaching $50.13. About 661,990 shares traded or 67.03% up from the average. Phillips 66 Partners LP (NYSE:PSXP) has declined 2.97% since February 17, 2018 and is downtrending. It has underperformed by 2.97% the S&P500. Some Historical PSXP News: 22/05/2018 – Phillips 66 Reports Tripped Compressors at Sweeny Refinery in Texas; 27/04/2018 – Phillips 66 Partners 1Q Adjusted Ebitda $247M; 24/04/2018 – BUCKEYE PARTNERS LP – CO WILL OWN A 50% INTEREST IN NEWLY FORMED JOINT VENTURE AND PHILLIPS 66 PARTNERS AND ANDEAVOR WILL EACH OWN A 25% INTEREST; 18/04/2018 – PHILLIPS 66 PARTNERS BOOSTS DISTRIBUTION TO 71.4C/UNIT; 18/04/2018 – Phillips 66 Partners Raises Distribution to 71.4c Vs. 67.8c; 24/04/2018 – PHILLIPS 66 PARTNERS LP – GRAY OAK PIPELINE, A JV OWNED 75 PCT BY CO AND 25 PCT BY ANDEAVOR WILL OWN PIPELINE SYSTEM; 23/03/2018 – DIARY-U.S. refinery operations-Phillips 66 Says Planned Work Underway at Bayway, NJ Refinery; 24/04/2018 – Phillips 66 Partners to Construct West Texas Crude Oil Pipeline System, Hold Second Open Season; 23/04/2018 – PHILLIPS 66 SAYS BORGER MAINTENANCE CRIMPING FUEL OUTPUT; 27/04/2018 – PHILLIPS 66 PARTNERS LP – WILL CONTINUE TO FUND ORGANIC PROJECTS IN 2018 WITH CASH ON HAND, DEBT CAPACITY AND SELECTIVE USE OF ATM PROGRAM

Among 17 analysts covering Phillips 66 Partners (NYSE:PSXP), 10 have Buy rating, 1 Sell and 6 Hold. Therefore 59% are positive. Phillips 66 Partners had 66 analyst reports since August 4, 2015 according to SRatingsIntel. The company was maintained on Wednesday, August 1 by Bank of America. Citigroup maintained Phillips 66 Partners LP (NYSE:PSXP) on Monday, July 17 with “Buy” rating. Stifel Nicolaus maintained Phillips 66 Partners LP (NYSE:PSXP) rating on Thursday, October 26. Stifel Nicolaus has “Buy” rating and $60.0 target. Stifel Nicolaus downgraded the shares of PSXP in report on Monday, February 11 to “Hold” rating. As per Monday, June 19, the company rating was maintained by RBC Capital Markets. On Friday, August 24 the stock rating was downgraded by JP Morgan to “Neutral”. The stock of Phillips 66 Partners LP (NYSE:PSXP) earned “Buy” rating by on Monday, October 10. The rating was initiated by Goldman Sachs with “Neutral” on Thursday, August 25. Citigroup maintained the shares of PSXP in report on Wednesday, October 18 with “Buy” rating. Scotia Capital maintained it with “Buy” rating and $60.0 target in Monday, January 29 report.

Investors sentiment decreased to 1.04 in Q3 2018. Its down 0.34, from 1.38 in 2018Q2. It dived, as 14 investors sold PSXP shares while 40 reduced holdings. 20 funds opened positions while 36 raised stakes. 47.72 million shares or 4.82% more from 45.53 million shares in 2018Q2 were reported. Moreover, Evergreen Cap Mngmt Ltd Liability has 0.04% invested in Phillips 66 Partners LP (NYSE:PSXP) for 9,925 shares. Blackrock owns 211,413 shares. Heronetta Mgmt Lp accumulated 15,500 shares. Tiedemann Limited Liability accumulated 1.13% or 374,762 shares. State Of Tennessee Treasury Department accumulated 109,947 shares. Principal Grp Incorporated Inc invested in 0.01% or 332,469 shares. Deutsche Financial Bank Ag has invested 0% in Phillips 66 Partners LP (NYSE:PSXP). Commonwealth Of Pennsylvania Pub School Empls Retrmt accumulated 491,471 shares. Guggenheim Cap Ltd invested 0.01% in Phillips 66 Partners LP (NYSE:PSXP). Susquehanna Int Gru Incorporated Ltd Liability Partnership reported 10,803 shares stake. Bancshares Of America De owns 538,588 shares. Spirit Of America Mngmt Ny holds 2.41% or 379,839 shares. Creative Planning holds 7,371 shares. The Oklahoma-based Pinnacle Limited Liability Com has invested 0% in Phillips 66 Partners LP (NYSE:PSXP). Mirae Asset Global Invs accumulated 964,703 shares.

Parkside Financial Bank & Trust, which manages about $288.48 million US Long portfolio, upped its stake in Ishares Tr (EFV) by 7,927 shares to 67,345 shares, valued at $3.50M in 2018Q3, according to the filing. It also increased its holding in Ishares Tr (IWB) by 3,675 shares in the quarter, for a total of 71,398 shares, and has risen its stake in Williams Cos Inc Del (NYSE:WMB).

More notable recent Phillips 66 Partners LP (NYSE:PSXP) news were published by: 247Wallst.com which released: “Phillips 66, Partner Taking Bids on New Crude Oil Pipeline – 24/7 Wall St.” on November 12, 2018, also Seekingalpha.com with their article: “Phillips 66 Partners: Hamstrung By The IDRs – Seeking Alpha” published on October 18, 2018, Globenewswire.com published: “Market Trends Toward New Normal in Nu Skin Enterprises, Phillips 66 Partners LP, Hilton Worldwide, John Bean Technologies, JBG SMITH Properties, and YRC Worldwide — Emerging Consolidated Expectations, Analyst Ratings – GlobeNewswire” on January 23, 2019. More interesting news about Phillips 66 Partners LP (NYSE:PSXP) were released by: Zacks.com and their article: “Phillips 66 Partners (PSXP) Hikes Quarterly Payout for Q4 – Zacks.com” published on January 23, 2019 as well as ‘s news article titled: “Phillips 66 (NYSE:PSXP) Downgraded By Morgan Stanley On Valuation – Benzinga” with publication date: September 28, 2018.

Since November 28, 2018, it had 2 insider purchases, and 0 insider sales for $538,241 activity. The insider O’Toole Joseph bought 10,000 shares worth $469,600.

Among 21 analysts covering Myriad Genetics (NASDAQ:MYGN), 8 have Buy rating, 4 Sell and 9 Hold. Therefore 38% are positive. Myriad Genetics had 76 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Underperform” rating given on Monday, July 16 by Bank of America. The rating was upgraded by Morgan Stanley on Wednesday, March 21 to “Equal-Weight”. The rating was upgraded by PiperJaffray to “Overweight” on Wednesday, October 10. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) earned “Sell” rating by Ladenburg Thalmann on Monday, October 10. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) earned “Overweight” rating by Piper Jaffray on Tuesday, September 15. The firm earned “Hold” rating on Monday, January 22 by Barclays Capital. Morgan Stanley maintained the stock with “Equal-Weight” rating in Wednesday, May 9 report. Piper Jaffray maintained it with “Hold” rating and $27.0 target in Sunday, October 15 report. The stock has “Neutral” rating by Mizuho on Wednesday, November 4. The company was maintained on Wednesday, November 8 by Morgan Stanley.